QRG Capital Management Inc. increased its stake in shares of Equifax, Inc. (NYSE:EFX - Free Report) by 196.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,852 shares of the credit services provider's stock after buying an additional 11,837 shares during the quarter. QRG Capital Management Inc.'s holdings in Equifax were worth $3,873,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of EFX. Allianz Asset Management GmbH boosted its holdings in Equifax by 6.0% in the third quarter. Allianz Asset Management GmbH now owns 392,560 shares of the credit services provider's stock valued at $100,703,000 after purchasing an additional 22,302 shares during the last quarter. Explore Capital Management LLC increased its holdings in shares of Equifax by 34.6% during the 3rd quarter. Explore Capital Management LLC now owns 40,930 shares of the credit services provider's stock valued at $10,500,000 after purchasing an additional 10,530 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Equifax by 27.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 767,982 shares of the credit services provider's stock worth $197,018,000 after acquiring an additional 163,866 shares in the last quarter. Envestnet Asset Management Inc. grew its position in shares of Equifax by 34.0% during the 3rd quarter. Envestnet Asset Management Inc. now owns 383,441 shares of the credit services provider's stock valued at $98,364,000 after acquiring an additional 97,347 shares during the period. Finally, Cinctive Capital Management LP purchased a new position in shares of Equifax in the 3rd quarter valued at about $2,837,000. Institutional investors and hedge funds own 96.20% of the company's stock.
Key Stories Impacting Equifax
Here are the key news stories impacting Equifax this week:
- Positive Sentiment: Zacks bumped its FY‑2026 EPS view (to $8.41) and raised Q3 2026 slightly, giving modest near‑term earnings support that can be taken as a positive signal for the company's 2026 outlook.
- Neutral Sentiment: Kalkine Media explains why Equifax is “in focus” now, summarizing investor attention around recent earnings, guidance and valuation — useful context but not a direct catalyst. Why Is Equifax Stock in Focus Right Now
- Negative Sentiment: Seeking Alpha downgraded Equifax to a Hold, citing near‑term uncertainty — analyst downgrades can pressure the stock by reducing conviction among momentum or growth investors. Equifax: Downgrading To Hold On Near-Term Uncertainty
- Negative Sentiment: Yahoo Finance highlights a 33.8% one‑year share price decline and asks whether the stock is worth reconsidering — renewed focus on the long slide can amplify selling pressure from momentum and risk‑averse investors. Is It Time To Reconsider Equifax (EFX) After A 33.8% One Year Share Price Slide
- Negative Sentiment: Zacks also cut multiple future quarterly and multi‑year estimates (notably FY‑2027/FY‑2028 and Q1‑2027), signaling some analyst caution on longer‑term trajectory — these revisions increase uncertainty around forward earnings growth and valuation.
Analysts Set New Price Targets
A number of equities analysts have issued reports on the company. Mizuho started coverage on Equifax in a research report on Thursday, April 16th. They set an "outperform" rating and a $222.00 price target on the stock. Bank of America began coverage on shares of Equifax in a research note on Tuesday, February 17th. They issued a "buy" rating and a $250.00 price target on the stock. Robert W. Baird decreased their price objective on shares of Equifax from $250.00 to $245.00 and set an "outperform" rating on the stock in a report on Wednesday, April 22nd. BNP Paribas Exane dropped their price target on Equifax from $210.00 to $195.00 and set a "neutral" rating for the company in a research report on Monday, April 27th. Finally, Oppenheimer decreased their price objective on Equifax from $271.00 to $266.00 and set an "outperform" rating on the stock in a report on Monday, January 12th. Thirteen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $228.88.
Get Our Latest Stock Report on EFX
Insider Buying and Selling
In other Equifax news, EVP John W. Gamble, Jr. sold 4,500 shares of Equifax stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $195.72, for a total value of $880,740.00. Following the completion of the transaction, the executive vice president directly owned 58,921 shares of the company's stock, valued at $11,532,018.12. The trade was a 7.10% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Mark W. Begor sold 37,791 shares of the business's stock in a transaction dated Friday, April 24th. The stock was sold at an average price of $172.40, for a total transaction of $6,515,168.40. Following the sale, the chief executive officer owned 271,730 shares in the company, valued at $46,846,252. This trade represents a 12.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 87,462 shares of company stock valued at $16,475,349. Corporate insiders own 1.70% of the company's stock.
Equifax Stock Up 1.9%
NYSE EFX opened at $173.29 on Thursday. Equifax, Inc. has a 52 week low of $166.02 and a 52 week high of $281.03. The firm has a market cap of $20.63 billion, a PE ratio of 30.51, a P/E/G ratio of 1.27 and a beta of 1.35. The business's fifty day simple moving average is $185.87 and its 200-day simple moving average is $202.29. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 0.89.
Equifax (NYSE:EFX - Get Free Report) last released its quarterly earnings data on Tuesday, April 21st. The credit services provider reported $1.86 EPS for the quarter, beating analysts' consensus estimates of $1.69 by $0.17. The firm had revenue of $1.65 billion for the quarter, compared to analysts' expectations of $1.61 billion. Equifax had a return on equity of 20.41% and a net margin of 11.12%.The firm's quarterly revenue was up 14.3% on a year-over-year basis. During the same period in the prior year, the firm posted $1.53 earnings per share. Equifax has set its Q2 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.340-8.740 EPS. As a group, equities analysts anticipate that Equifax, Inc. will post 8.57 earnings per share for the current year.
Equifax Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were issued a $0.56 dividend. This is a boost from Equifax's previous quarterly dividend of $0.50. The ex-dividend date was Monday, March 9th. This represents a $2.24 annualized dividend and a yield of 1.3%. Equifax's payout ratio is 39.44%.
Equifax Company Profile
(
Free Report)
Equifax Inc NYSE: EFX is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.
The company's offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report